Creative Medical Technology Holdings shares fall 2.03% in after-hours trading.

miércoles, 9 de julio de 2025, 4:02 pm ET1 min de lectura
CELZ--
Creative Medical Technology Holdings, Inc. fell 2.03% in after-hours trading, as the company, a commercial-stage biotechnology firm focused on innovative biotherapeutics, including immunotherapies and endocrinology, reported on the availability of its CaverStem and FemCelz kits for treating sexual dysfunction through its subsidiaries in eight U.S. locations.

Creative Medical Technology Holdings shares fall 2.03% in after-hours trading.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios